Jaai Manare, Mellouki Haytam, El Oumri Ahmed Amine
Physical Medicine and Rehabilitation, University Hospital Center Mohammed VI Oujda Morocco, Oujda, MAR.
Physical Medicine and Rehabilitation, Faculty of Medicine of Oujda, Mohammed VI University Hospital of Oujda, Mohammed First University of Oujda, Oujda, MAR.
Cureus. 2024 Dec 18;16(12):e75968. doi: 10.7759/cureus.75968. eCollection 2024 Dec.
Background Morton's neuroma is a common cause of forefoot pain, typically occurring in the third metatarsal space and characterized by symptomatic nerve compression. This condition often leads to significant functional impairment, affecting weight-bearing activities and limiting appropriate footwear due to pain and discomfort. Objective This study aims to evaluate the outcomes of conservative interventional treatment for Morton's neuroma, specifically focusing on corticosteroid injections. Methodology We reviewed 10 cases of Morton's neuroma in the field of physical medicine and rehabilitation. The average age of the patients was 45 years, with a higher prevalence among females. Diagnoses were confirmed through clinical assessment and ultrasound imaging. Results All 10 patients (100%) received conservative interventional treatment with corticosteroid injections. This approach effectively alleviated symptoms in 9 out of 10 patients (90%). Surgical options were considered only if symptoms did not improve with this treatment. Conclusions All 10 patients (100%) were treated with corticosteroid injections, which alleviated symptoms in 9 out of 10 patients (90%). Surgical options were considered only if this treatment was insufficient. This analysis highlights the effectiveness of this approach as a first-line management strategy for Morton's neuroma.
莫顿神经瘤是前足疼痛的常见原因，通常发生在第三跖骨间隙，其特征为有症状的神经受压。这种情况常导致显著的功能障碍，影响负重活动，并因疼痛和不适而限制合适鞋类的选择。目的：本研究旨在评估莫顿神经瘤保守介入治疗的效果，特别关注皮质类固醇注射。方法：我们回顾了物理医学与康复领域的10例莫顿神经瘤病例。患者的平均年龄为45岁，女性患病率更高。通过临床评估和超声成像确诊。结果：所有10例患者（100%）均接受了皮质类固醇注射的保守介入治疗。该方法在10例患者中有9例（90%）有效缓解了症状。仅在该治疗无效时才考虑手术选择。结论：所有10例患者（100%）均接受了皮质类固醇注射治疗，其中9例（90%）症状得到缓解。仅在该治疗不足时才考虑手术选择。该分析突出了这种方法作为莫顿神经瘤一线治疗策略的有效性。
